Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
38M
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
37.8M
-
Shares change
-
+848K
-
Total reported value, excl. options
-
$377M
-
Value change
-
+$70.8M
-
Put/Call ratio
-
0.83
-
Number of buys
-
94
-
Number of sells
-
-64
-
Price
-
$9.97
Significant Holders of ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q2 2025
177 filings reported holding ITOS - ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q2 2025.
ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) has 134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.8M shares
of 38M outstanding shares and own 99.58% of the company stock.
Largest 10 shareholders include EcoR1 Capital, LLC (10.7M shares), BlackRock, Inc. (4.57M shares), TANG CAPITAL MANAGEMENT LLC (3.83M shares), VANGUARD GROUP INC (1.66M shares), DIMENSIONAL FUND ADVISORS LP (833K shares), Boxer Capital Management, LLC (825K shares), GEODE CAPITAL MANAGEMENT, LLC (703K shares), ORBIMED ADVISORS LLC (700K shares), MARSHALL WACE, LLP (612K shares), and RENAISSANCE TECHNOLOGIES LLC (602K shares).
This table shows the top 134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.